ALX Oncology Holdings Inc (ALXO)

1.29 -0.04 (-3.01%) USD  |  NASDAQ  |  Nov 15, 16:00
1.29 0.00 (0.00%) After-Hours: 19:31
More

ALX Oncology Holdings Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for ALXO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Non-Current Deferred Revenue (Quarterly) Data

View and export this data back to 2020. Upgrade now.
Date Value
June 30, 2020 --
Date Value
March 31, 2020 --

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

--
Minimum
Jun 2020
Upgrade
Maximum
Mar 2020
Upgrade
Average
Upgrade
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

Biomarin Pharmaceutical Inc --
Neurocrine Biosciences Inc --
Eton Pharmaceuticals Inc --
Verve Therapeutics Inc Upgrade
Immuneering Corp --